Free shipping on all orders over $ 500

Monomethyl auristatin E

Cat. No. M3741

All AbMole products are for research use only, cannot be used for human consumption.

Monomethyl auristatin E Structure
Synonym:

MMAE, Vedotin; SGD-1010

Size Price Availability Quantity
5mg USD 30  USD30 In stock
10mg USD 45  USD45 In stock
50mg USD 100  USD100 In stock
100mg USD 160  USD160 In stock
250mg USD 250  USD250 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Monomethyl auristatin E (MMAE; Vedotin) is an antimitotic agent which inhibits cell division by blocking the polymerisation of tubulin. Monomethyl auristatin E (MMAE), linked via the lysosomally cleavable dipeptide, valine-citrulline (vc). Antibody-drug conjugates (ADCs) are designed to combine the exquisite specificity of antibodies to target tumor antigens with the cytotoxic potency of chemotherapeutic drugs. In vivo studies demonstrated that the peptide-linked conjugates induced regressions and cures of established tumor xenografts with therapeutic indices as high as 60-fold.*The compound is unstable in solutions, freshly prepared is recommended


Protocol (for reference only)
Cell Experiment
Cell lines CD30+ Karpas 299 cells
Preparation method Using Alamar Blue dye reduction assay to measure cytotoxicity according to the manufacturer's directions. Briefly, freshly preparing a 40% solution (wt/vol) of Alamar Blue in complete media just before adding cultures . Ninety-two hours after drug exposure, adding Alamar Blue solution to cells to constitute 10% culture volume. Incubating cells for 4 hours, and measuring dye reduction on a Fusion HT fluorescent plate reader (Packard Instruments, Meriden, CT).
Concentrations ~1000 ng/mL
Incubation time 96 h
Animal Experiment
Animal models SCID mice bearing Karpas 299 (ALCL) or L540cy (HD) tumors
Formulation
Dosages 0.36 mg/kg
Administration i.v.
Chemical Information
Molecular Weight 717.98
Formula C39H67N5O7
CAS Number 474645-27-7
Solubility (25°C) DMSO >48 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Ariana Abawi, et al. Monomethyl Auristatin E Grafted-Liposomes to Target Prostate Tumor Cell Lines

[2] Marie Alt, et al. Enfortumab Vedotin in urothelial cancer

[3] Elisabeth I Heath, et al. The biology and rationale of targeting nectin-4 in urothelial carcinoma

[4] Bradley A McGregor, et al. Enfortumab Vedotin, a fully human monoclonal antibody against Nectin 4 conjugated to monomethyl auristatin E for metastatic urothelial Carcinoma

[5] Joseph A Francisco, et al. cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity

Related Microtubule Products
CCB02

CCB02 is a selective CPAP-tubulin interaction inhibitor, binding to tubulin and competing for the CPAP binding site of β-tubulin, with an IC50 of 689 nM, and shows potent anti-tumor activity.

Lisavanbulin

Lisavanbulin (BAL-101553) is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

20-O-Demethyl-AP3 

20-O-Demethyl-AP3 is a minor metabolite of Ansamitocin P-3.

Lisavanbulin dihydrochloride

Lisavanbulin (BAL-101553) dihydrochloride is the prodrug of the microtubule targeting agent Avanbulin (BAL 27862).

Paclitaxel-d5

Paclitaxel-d5

  Catalog
Abmole Inhibitor Catalog




Keywords: Monomethyl auristatin E, MMAE, Vedotin; SGD-1010 supplier, Microtubule, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.